Boundless Bio Ownership | Who Owns Boundless Bio?
Boundless Bio Ownership Summary
Boundless Bio is owned by 43.78% institutional investors, 11.40% insiders, and 44.83% retail investors. Sectoral asset management is the largest institutional shareholder, holding 3.04% of BOLD shares.
BOLD Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Boundless Bio | 43.78% | 11.40% | 44.83% |
Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Sectoral asset management | 678.57K | 3.04% | $685.36K |
Redmile group | 589.03K | 2.63% | $594.92K |
Alyeska investment group | 300.00K | 1.34% | $303.00K |
Almitas capital | 235.50K | 1.05% | $237.86K |
Rbf capital | 200.00K | 0.89% | $202.00K |
Ensign peak advisors | 187.50K | 0.84% | $189.38K |
Sio capital management | 163.68K | 0.73% | $165.32K |
Stonepine capital management | 106.17K | 0.47% | $107.24K |
Blackrock funding, inc. /de | 64.26K | 0.29% | $64.90K |
Y-intercept (hong kong) | 55.24K | 0.25% | $55.79K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Sectoral asset management | 678.57K | 0.45% | $685.36K |
Stonepine capital management | 106.17K | 0.11% | $107.24K |
Redmile group | 589.03K | 0.06% | $594.92K |
Sio capital management | 163.68K | 0.06% | $165.32K |
Almitas capital | 235.50K | 0.06% | $237.86K |
Rbf capital | 200.00K | 0.01% | $202.00K |
Abel hall | 14.40K | 0.01% | $14.54K |
Xtx topco | 40.06K | 0.00% | $40.47K |
Y-intercept (hong kong) | 55.24K | 0.00% | $55.79K |
Alyeska investment group | 300.00K | 0.00% | $303.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rbf capital | 200.00K | 0.01% | 200.00K |
Stonepine capital management | 106.17K | 0.11% | 106.17K |
Y-intercept (hong kong) | 55.24K | 0.00% | 55.24K |
Hrt financial lp | 27.51K | 0.00% | 27.51K |
Qube research | 21.54K | - | 21.54K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ra capital management | - | - | -2.18M |
Blackrock funding, inc. /de | 64.26K | - | -563.94K |
Pfm health sciences, lp | - | - | -240.51K |
Ubs oconnor | - | - | -140.00K |
Redmile group | 589.03K | 0.06% | -136.17K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Rbf capital | 200.00K | 0.01% | 200.00K | $202.00K |
Stonepine capital management | 106.17K | 0.11% | 106.17K | $107.24K |
Y-intercept (hong kong) | 55.24K | 0.00% | 55.24K | $55.79K |
Hrt financial lp | 27.51K | 0.00% | 27.51K | $27.00K |
Qube research | 21.54K | - | 21.54K | $21.76K |
Sold Out
Holder | Change |
---|---|
True wealth design | -5.00 |
Deutsche bank ag\ | -97.00 |
Sterling capital management | -119.00 |
Nelson, van denburg & campbell wealth management group | -122.00 |
Nisa investment advisors | -208.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 42 | -20.75% | 9,787,223 | -42.33% | 43 | 0.76% | 18 | -14.29% | 17 | 13.33% |
Mar 31, 2025 | 5 | -90.74% | 3,986,980 | -69.24% | 17 | 0.53% | - | -100.00% | 1 | -66.67% |
Dec 31, 2024 | 54 | 1.89% | 12,962,527 | -1.19% | 58 | 1.68% | 37 | 60.87% | 3 | -81.25% |
Sep 30, 2024 | 53 | 12.77% | 13,118,509 | -5.23% | 58 | 1.49% | 23 | -30.30% | 16 | 100.00% |
Jun 30, 2024 | 47 | 11.90% | 13,842,210 | -4.62% | 62 | 1.48% | 33 | -21.43% | 8 | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 08, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $432.78K |
Aug 12, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $34.52K |
Aug 12, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $646.31K |
Feb 25, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $120.00K |
Oct 01, 2018 | Patterson Matthew R | Chief Executive Officer | Sell | $202.73K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2020 Q1 | - | - |
2019 Q4 | - | 1 |
2019 Q3 | - | 2 |
2019 Q2 | - | - |
BOLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools